Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 2,141 $ 3,375
Cost of revenue 1,067 1,569
Gross profit 1,074 1,806
Operating expenses:    
Sales and marketing 2,051 1,707
Research and development 583 988
General and administrative 4,058 2,551
Total operating expenses 6,692 5,246
Loss from operations (5,618) (3,440)
Other (expense) income, net:    
Interest expense, net (143) (72)
(Loss) gain on revaluation of warrant liabilities (727) 1
Finance cost associated with warrant issuance (145) 0
Unrealized (loss) gain on foreign exchange (239) 626
Other expense, net (13) (6)
Total other (expense) income, net (1,267) 549
Net loss (6,885) (2,891)
Other comprehensive income (loss) 210 (533)
Comprehensive loss $ (6,675) $ (3,424)
Net loss per share applicable to common stockholders, basic and diluted (in dollars per share) $ (2.04) $ (1.84)
Weighted average number of common shares outstanding, basic and diluted (in shares) 3,563 1,693